AstraZeneca to buy US-based CinCor Pharma in $1.8 billion deal
AstraZeneca said it will pay $26 per CinCor share in cash, a premium of nearly 121 per cent to the stock's closing price
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.